10X Genomics, Inc. (TXG)
63.79
-1.33
(-2.04%)
USD |
NASDAQ |
Aug 24, 16:00
63.79
0.00 (0.00%)
After-Hours: 20:00
10X Genomics Total Liabilities (Quarterly) : 204.52M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 204.52M |
| March 31, 2026 | 201.44M |
| December 31, 2025 | 245.04M |
| September 30, 2025 | 242.24M |
| June 30, 2025 | 206.69M |
| March 31, 2025 | 196.50M |
| December 31, 2024 | 208.50M |
| September 30, 2024 | 214.99M |
| June 30, 2024 | 205.61M |
| March 31, 2024 | 204.08M |
| December 31, 2023 | 224.10M |
| September 30, 2023 | 203.32M |
| June 30, 2023 | 196.34M |
| March 31, 2023 | 211.64M |
| December 31, 2022 | 223.24M |
| September 30, 2022 | 220.42M |
| June 30, 2022 | 218.08M |
| March 31, 2022 | 196.57M |
| Date | Value |
|---|---|
| December 31, 2021 | 201.26M |
| September 30, 2021 | 190.35M |
| June 30, 2021 | 192.99M |
| March 31, 2021 | 201.57M |
| December 31, 2020 | 190.27M |
| September 30, 2020 | 217.46M |
| June 30, 2020 | 191.53M |
| March 31, 2020 | 201.32M |
| December 31, 2019 | 185.84M |
| September 30, 2019 | 151.37M |
| June 30, 2019 | 383.54M |
| March 31, 2019 | |
| December 31, 2018 | 344.30M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 188.12M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 226.70M |
| Alamar Biosciences, Inc. (California) | 78.12M |
| Personalis, Inc. | 76.97M |
| Adaptive Biotechnologies Corp. | 490.02M |
| Champions Oncology, Inc. | 22.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.030B |
| Shareholders Equity (Quarterly) | 825.55M |
| Debt to Equity Ratio | 0.0954 |
| Current Ratio | 5.693 |
| Net Debt Paydown Yield | 0.01% |